http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5578001-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a1b1b9a1612ba7721b7041aa9185512
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6284e5a807735504d046570129e4246
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00
filingDate 1978-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8560fb28685d4c091b04107e569a57a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ab651e8f67b58222dfea0ee384ad43d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_158598cd12264a6f6679842700fc7e19
publicationDate 1980-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S5578001-A
titleOfInvention Polysaccharide-polypeptide combination having beta(1-3), (1-6) glucan structure and its preparation
abstract PURPOSE: To obtain the title novel compound useful as oral antitumor, liver function improving, antidepressive, and antihyperlipemia drugs, by reacting the reaction product between a specific polysaccharide and a cyanogen halide with a polypeptide. n CONSTITUTION: The hydroxyl group in the side chain or cleaved terminal glucose ring of the (1-6) bond in (A) a polysaccharide, D-11 of the formula I or its derivative, obtained from mycelia is reacted with (B) a cyanogen halide or perhalogenate. (C) A polypeptide having terminal amino groups, e.g. bovine serum albumin, is reacted with the reaction product thus obtained to give the objective compound. The component (A) is preferably prepared by extracting and purifying a cultured mycelia of Ceriolus Versicolor IWADE. n COPYRIGHT: (C)1980,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106323895-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7776843-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7648968-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100563616-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2314850-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2314850-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7622575-B2
priorityDate 1978-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456491178

Total number of triples: 22.